Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment
The aim of the study was to evaluate the immunoregulatory activity of an experimental drug based on ultra-high dilutions of antibodies to MHC I and MHC II molecules against Salmonella enteritidis rif92.Materials and methods. The drug tested: a sample of ultra-high water-alcohol dilutions of antibodi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2021-07-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/4384 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849241364753022976 |
|---|---|
| author | M. G. Teymurazov N. V. Petrova E. A. Karelina K. K. Ganina S. A. Tarasov O. I. Epstein |
| author_facet | M. G. Teymurazov N. V. Petrova E. A. Karelina K. K. Ganina S. A. Tarasov O. I. Epstein |
| author_sort | M. G. Teymurazov |
| collection | DOAJ |
| description | The aim of the study was to evaluate the immunoregulatory activity of an experimental drug based on ultra-high dilutions of antibodies to MHC I and MHC II molecules against Salmonella enteritidis rif92.Materials and methods. The drug tested: a sample of ultra-high water-alcohol dilutions of antibodies to MHC I and MHC II molecules applied to lactose powder (the theoretical level of the initial antibody concentration reduction is at least 1024 times). A model of non-lethal Salmonella infection in chickens was induced by administering a virulent strain of Salmonella enteritidis rif92 with a concentration of 2.5 × 109 CFU/g in the volume of 0.5 ml/bird. The following groups were formed (n = 15 in each group): 1 – drug; 2 – drug + antibiotic at the median effective dose (ED 50); 3 – placebo; 4 – placebo + antibiotic at ED50; 5 – intact control. The duration of the experiment was 12 days. The studied parameters included the survival rate during the observation period; daily body weight; feed consumption for the entire period; pathogen concentration in the litter on day 3, 6, and 9; the presence and concentration of the pathogen in the liver and cecum on day 12; and the index of antimicrobial activity on day 12.Results. In the groups receiving the experimental drug, the infectious process proceeded in a milder form and the bacterial load in chickens was lower. The bacterial count in the litter was reduced by two orders compared to the respective control when the drug was added both alone and in combination with the antibiotic. A protective effect of the experimental drug on the liver of the infected chickens was detected.Conclusion. A pronounced immunoregulatory activity of the studied drug against Salmonella enteritidis rif92 in chickens was demonstrated for the first time. The results obtained allow to consider the drug as a promising agentfor the treatment of Salmonella infection. |
| format | Article |
| id | doaj-art-c7513359aac2450c876fffb90ef67dcf |
| institution | Kabale University |
| issn | 1682-0363 1819-3684 |
| language | English |
| publishDate | 2021-07-01 |
| publisher | Siberian State Medical University (Tomsk) |
| record_format | Article |
| series | Бюллетень сибирской медицины |
| spelling | doaj-art-c7513359aac2450c876fffb90ef67dcf2025-08-20T04:00:12ZengSiberian State Medical University (Tomsk)Бюллетень сибирской медицины1682-03631819-36842021-07-012029510110.20538/1682-0363-2021-2-95-1012786Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatmentM. G. Teymurazov0N. V. Petrova1E. A. Karelina2K. K. Ganina3S. A. Tarasov4O. I. Epstein5State Research Center for Applied Microbiology and Biotechnology (SRCAMB)Institute of General Pathology and Pathophysiology (IGPP); MATERIA MEDICA HOLDING LLC, Research and Production CompanyMATERIA MEDICA HOLDING LLC, Research and Production CompanyMATERIA MEDICA HOLDING LLC, Research and Production CompanyInstitute of General Pathology and Pathophysiology (IGPP); MATERIA MEDICA HOLDING LLC, Research and Production CompanyInstitute of General Pathology and Pathophysiology (IGPP); MATERIA MEDICA HOLDING LLC, Research and Production CompanyThe aim of the study was to evaluate the immunoregulatory activity of an experimental drug based on ultra-high dilutions of antibodies to MHC I and MHC II molecules against Salmonella enteritidis rif92.Materials and methods. The drug tested: a sample of ultra-high water-alcohol dilutions of antibodies to MHC I and MHC II molecules applied to lactose powder (the theoretical level of the initial antibody concentration reduction is at least 1024 times). A model of non-lethal Salmonella infection in chickens was induced by administering a virulent strain of Salmonella enteritidis rif92 with a concentration of 2.5 × 109 CFU/g in the volume of 0.5 ml/bird. The following groups were formed (n = 15 in each group): 1 – drug; 2 – drug + antibiotic at the median effective dose (ED 50); 3 – placebo; 4 – placebo + antibiotic at ED50; 5 – intact control. The duration of the experiment was 12 days. The studied parameters included the survival rate during the observation period; daily body weight; feed consumption for the entire period; pathogen concentration in the litter on day 3, 6, and 9; the presence and concentration of the pathogen in the liver and cecum on day 12; and the index of antimicrobial activity on day 12.Results. In the groups receiving the experimental drug, the infectious process proceeded in a milder form and the bacterial load in chickens was lower. The bacterial count in the litter was reduced by two orders compared to the respective control when the drug was added both alone and in combination with the antibiotic. A protective effect of the experimental drug on the liver of the infected chickens was detected.Conclusion. A pronounced immunoregulatory activity of the studied drug against Salmonella enteritidis rif92 in chickens was demonstrated for the first time. The results obtained allow to consider the drug as a promising agentfor the treatment of Salmonella infection.https://bulletin.ssmu.ru/jour/article/view/4384salmonellosisultra-high dilutions of antibodiesmhc class i and ii moleculesantibioticschickens |
| spellingShingle | M. G. Teymurazov N. V. Petrova E. A. Karelina K. K. Ganina S. A. Tarasov O. I. Epstein Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment Бюллетень сибирской медицины salmonellosis ultra-high dilutions of antibodies mhc class i and ii molecules antibiotics chickens |
| title | Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment |
| title_full | Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment |
| title_fullStr | Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment |
| title_full_unstemmed | Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment |
| title_short | Nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment |
| title_sort | nonclinical study of the new immunotropic drug effectiveness in salmonella infection treatment |
| topic | salmonellosis ultra-high dilutions of antibodies mhc class i and ii molecules antibiotics chickens |
| url | https://bulletin.ssmu.ru/jour/article/view/4384 |
| work_keys_str_mv | AT mgteymurazov nonclinicalstudyofthenewimmunotropicdrugeffectivenessinsalmonellainfectiontreatment AT nvpetrova nonclinicalstudyofthenewimmunotropicdrugeffectivenessinsalmonellainfectiontreatment AT eakarelina nonclinicalstudyofthenewimmunotropicdrugeffectivenessinsalmonellainfectiontreatment AT kkganina nonclinicalstudyofthenewimmunotropicdrugeffectivenessinsalmonellainfectiontreatment AT satarasov nonclinicalstudyofthenewimmunotropicdrugeffectivenessinsalmonellainfectiontreatment AT oiepstein nonclinicalstudyofthenewimmunotropicdrugeffectivenessinsalmonellainfectiontreatment |